A recent cluster of 40 cases in Chicago suggests that vaccine protection may wane over time, but vaccinated patients do well recovering at home.
For those who got sick, vaccinated patients had fewer symptoms and none required hospitalization.
With record dengue cases already this year, Peru is bracing for more heavy rains in the months ahead from the El Nino weather pattern.
Scientists used artificial intelligence to diagnose mpox using photos of skin lesions with an accuracy up to 99.5%.
Among 16 men who have sex with men infected with mpox, viral DNA remained detectable for 17 to 31 days after symptom onset.
The FDA antimicrobial drugs advisory committee unanimously recommended nirsevimab for preventing respiratory syncytial virus in infants during their first RSV season.
Fourteen suspected and 11 probable US meningitis cases have been reported in an outbreak tied to cosmetic surgery in clinics in Matamoros, Mexico.
Seven linked transmission chains were noted, including 3 patients who had linked partners who were female sex workers.
The organizations recommend 4 actions to help prevent and manage any future outbreaks.
The WHO declared a public health emergency of international concern in July 2022 following the global spread of the virus.
Local adverse event rates were highest following intradermal vaccine administration.
Africa has had a 7.4% case increase, with 111 new infections in the most recent 2 weeks.
Nine mpox patients had new skin or mucosal lesions after completing the 14-day Tpoxx treatment course.
Activity is rising in the Western Pacific due to local transmission in Japan, South Korea, and China.
No transmission was noted in encampments, despite potential sharing of sleeping bags, clothes, and utensils.
Only 17.1% of the US population live within 15 minutes of a vaccination site, and 50% live more than an hour away.
The proportion of cases in vaccinated patients was much higher than the previous 4 months.
The Americas reported the vast majority of new cases over the past 3 weeks—408 of 442.
Of the 85 videos analyzed, only 33% covered all content items that were highlighted in clinical practice guidelines.
Estimated 1-dose protection against symptomatic mpox was 78% after at least 14 days, ranging from 71% to 85% in sensitivity analyses.
The average time for symptom onset between successive cases (serial interval) is 8.5 days, and the time from infection to symptom onset (incubation period) is 5.6 days, new data show.
Experts conclude that sustained incidence of illness in a few nations, along with underreported detection of cases, was enough to maintain emergency status.
The estimated vaccine effectiveness of one subcutaneous dose of the Jynneos mpox vaccine among men in Israel is 86%.
The WHO says cases have risen 1%, and, of 11 countries reporting increases, the largest was in Mexico.
The disease has historically been defined via household contact, or animal-to-human contact via the ingestion of bushmeat.